Astri Dwyanti Tagueha

Astri Dwyanti Tagueha

Auto-generated profile, based on publicly available information

Astri Dwyanti Tagueha

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome 00185, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
MFMaria Gioia Fabiano
Maria Gioia Fabiano
LMLinda Maurizi
Linda Maurizi
JFJacopo Forte
Jacopo Forte
EDEleonora D'Intino
Eleonora D'Intino
MAMaria Grazia Ammendolia
Maria Grazia Ammendolia
CLCatia Longhi
Catia Longhi
Nanocarrier-based drug delivery systems (DDS) offer promising strategies to enhance therapeutic efficacy, stability, and targeted delivery of bioactive compounds while reducing side effects. In this study, a multidisciplinary approach was employed to develop and characterize bioactive liposomes incorporating resveratrol (RV), a polyphenol with known therapeutic potential but limited bioavailability, and Thymus vulgaris essential oil (TEO), recognized for its antimicrobial and antioxidant properties. To obtain stable nanocarriers, liposomes were formulated using soy lecithin and prepared by thin layer evaporation technique followed by sonication process. To assess the preservation of TEO's chemical profile during formulation, Headspace Solid Phase Microextraction coupled with Gas Chromatography–Mass Spectrometry (HS-SPME/GC-MS) was performed. Quantitative analysis of thymol and carvacrol, the two main active components, was performed by HPLC-UV experiments. Physicochemical characterization of DDS was carried out employing Dynamic Light Scattering (DLS), UV–Vis spectrophotometer and Transmission electron microscopy. Antimicrobial activity was assessed by broth microdilution method, while biofilm inhibition ability was evaluated using crystal violet staining. The obtained nanocarriers exhibited appropriate physicochemical characteristics, including optimal particle size and stability. They can efficiently load both oil and RV. These features enhanced the antibacterial activity of LT-RV compared to free RV, and improved its inhibitory effect, at sub-MIC concentrations, against the sessile form of Listeria monocytogenes strains. This study highlights the importance of integrating chemical, physical, and biological evaluations to develop effective nanocarrier-based formulations with the aim to identify a suitable strategy to combat infections associated with resistant, biofilm-producing pathogens, and offer a versatile and effective delivery platform.

1 January 2025 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
ABAmina Bougouizi
Amina Bougouizi
ATAstri Dwyanti Tagueha
Astri Dwyanti Tagueha
Daniela ScribanoDaniela Scribano
Daniela Scribano
ZCZohra Chekroud
Zohra Chekroud
ZLZahrat el Imen Lamraoui
Zahrat el Imen Lamraoui
HRHamza Rahab
Hamza Rahab
Escherichia coli is a leading cause of both community‐acquired and nosocomial infections. In particular, E. coli is responsible for 90% of all uncomplicated urinary tract infections (UTIs) and 65% of complicated UTIs. Among complicated UTIs, those caused by third‐generation cephalosporin (3GC)–resistant E. coli strains, expressing extended‐spectrum beta‐lactamases (ESBLs), are on the rise. These strains show often a multidrug‐resistant (MDR) phenotype, limiting the therapeutic options and the increasing incidence of MDR E. coli in Algeria is concerning. This study aims to compare the antibiotic resistance rates and profiles as well as the virulence traits between 3CG‐resistant E. coli isolates, collected from Algerian inpatients (IPs) and outpatients (OPs). Our analyses include phenotypic and genotypic resistance factor detection, strains classification by genotyping and phylogrouping, as well as genotypic and phenotypic virulence factor evaluation. Among 42 E. coli isolates, 76.20% caused UTIs. ESBL producers ( n = 35) carried all the b l a CTX−M , while b l a TEM was found in 69.04% of isolates. All isolates were MDR, and no significant differences in type and rate of antibiotic resistance were observed between IP‐ and OP‐isolates. OP‐isolates demonstrated greater virulence, exhibiting higher motility and biofilm production, compared to IP‐isolates. Moreover, pathogenic Phylogroup B2 was prevalent among OP‐isolates, while IP‐isolates belonged predominantly to Phylogroup A. Our data suggest a uniform spreading of antibiotic‐resistant genes within hospitals and communities. However, hospital environment selects for less virulent strains with increasing level of resistance; differently, communities host more virulent strains. This study highlights the urgent need to implement the surveillance of 3CG‐resistant E. coli and to adopt the One Health approach to monitor the antimicrobial resistance (AMR) in the country.